Irinotecan and loss of consciousness 
Irinotecan and loss of consciousness Patient Reports February 10, 2010
Irinotecan Side Effects Report #5290842-5
Irinotecan side effect was reported by a Health Professional from JAPAN on Mar 29, 2007. Female patient, weighting 172.0 lb, was diagnosed with sarcoma uterus, pancytopenia and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: blood pressure decreased, coagulation test abnormal, disseminated intravascular coagulation, dyspnoea, enterococcal infection, haemoglobin decreased, leukopenia, loss of consciousness, neutropenia. Irinotecan dosage: unknown. During the same period patient was treated with FRESH FROZEN PLASMA, SEROTONE, LASIX, OXYCONTIN. Patient died on 11/29/2006.
Irinotecan Side Effects Report #4950290-1
Irinotecan side effect was reported by a Physician from JAPAN on Mar 02, 2006. Female patient, 52 years of age, weighting 97.00 lb, was diagnosed with rectal cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, discomfort, electrocardiogram t wave inversion, fall
, loss of consciousness, malaise, nausea , urinary incontinence . Irinotecan dosage: 130 MG/BODY (INTERMITTENT), INTRAVENOUS. During the same period patient was treated with FLUOROURACIL, CALCIUM LEVOFOLINATE. Patient was hospitalized. Patient recovered.Irinotecan Side Effects Report #5362679-X
Irinotecan side effect was reported by a Health Professional from JAPAN on June 06, 2007. Male patient, weighting 105.8 lb, was diagnosed with rectal cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: loss of consciousness, nausea
. Irinotecan dosage: DAILY DOSE:220MG. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM, NASEA, DECADRON, GLIMICRON. Patient was hospitalized. Patient recovered.Irinotecan Side Effects Report #5370954-8
Irinotecan side effect was reported by a Health Professional from JAPAN on June 15, 2007. Male patient, weighting 105.8 lb, was diagnosed with rectal cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: convulsion, loss of consciousness, metabolic acidosis, nausea
. Irinotecan dosage: DAILY DOSE:220MG. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM, NASEA, DECADRON, GLIMICRON. Patient was hospitalized. Patient recovered.Irinotecan Side Effects Report #5086169-7
Irinotecan side effect was reported by a Physician from JAPAN on Aug 08, 2006. Female patient, 70 years of age, was diagnosed with ovarian cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: dizziness postural, hypokalaemia, incontinence, loss of consciousness. Irinotecan dosage: 100 MG/M2 (CYCLIC), INTRAVENOUS - MIDDLE OF JULY. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5096805-7
Irinotecan side effect was reported by a Physician from JAPAN on Aug 11, 2006. Female patient, 70 years of age, weighting 89.29 lb, was diagnosed with ovarian cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: blood pressure decreased, heart rate abnormal, hypokalaemia, loss of consciousness, syncope vasovagal, urinary incontinence
. Irinotecan dosage: unknown. During the same period patient was treated with NORVASC. Patient was hospitalized. Patient recovered.Irinotecan Side Effects Report #5279507-3
Irinotecan side effect was reported by a Physician from JAPAN on Mar 16, 2007. Female patient, weighting 89.29 lb, was diagnosed with ovarian cancer, hypertension and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: diarrhoea, hypokalaemia, loss of consciousness, vomiting. Irinotecan dosage: DAILY DOSE:100MG/M2-FREQ:CYCLIC. During the same period patient was treated with NORVASC, PURSENNID. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5056287-8
Irinotecan side effect was reported by a Physician from JAPAN on June 30, 2006. Male patient, 78 years of age, weighting 131.0 lb, was diagnosed with lung neoplasm malignant and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: chills, electrocardiogram qrs complex prolonged, flushing, heart rate increased, hypoxia, interstitial lung disease, loss of consciousness, respiratory arrest, shock. Irinotecan dosage: 95 MG, INTRAVENOUS. During the same period patient was treated with DECADRON, KYTRIL. Patient died on 06/29/2006.
Irinotecan Side Effects Report #5096737-4
Irinotecan side effect was reported by a Physician from JAPAN on June 30, 2006. Male patient, 78 years of age, weighting 131.0 lb, was diagnosed with lung neoplasm malignant and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: electrocardiogram qrs complex prolonged, flushing, heart rate increased, hypoxia, infection
, interstitial lung disease, leukopenia, loss of consciousness, lymphangiosis carcinomatosa. Irinotecan dosage: 95 MG (INTERMITTENT), INTRAVENOUS. During the same period patient was treated with DECADRON, KYTRIL. Patient died on 06/29/2006.Irinotecan Side Effects Report #5125992-7
Irinotecan side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 10, 2006. Male patient, weighting 161.6 lb, was diagnosed with glioblastoma multiforme and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: loss of consciousness, pneumocystis jiroveci pneumonia, pyrexia. Irinotecan dosage: 125MG/M2 DAY 1, 8, 22, 29 IV. During the same period patient was treated with TEMODAR, DECADRON, ZANTAC, FLORINEF. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5154508-4
Irinotecan side effect was reported by a Physician from GERMANY on Dec 17, 1998. Male patient, 63 years of age, was diagnosed with colorectal cancer
and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: circulatory collapse, ill-defined disorder, loss of consciousness. Irinotecan dosage: 350 MG, INTRAVENOUS. During the same period patient was treated with AMINOPHYLLIN, BUDESONIDE, LOPERAMIDE, TERBUTALINE SULPHATE. Patient was hospitalized. Patient died on 12/28/1998.Irinotecan Side Effects Report #4938515-X
Irinotecan side effect was reported by a Physician from JAPAN on Feb 17, 2006. Female patient, 53 years of age, was diagnosed with colorectal cancer
and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: loss of consciousness. Irinotecan dosage: 130 MG, INTRAVENOUS. During the same period patient was treated with FLUOROURACIL, CALCIUM LEVOFOLINATE. Patient was hospitalized. Patient recovered.Irinotecan Side Effects Report #5332614-9
Irinotecan side effect was reported by a Health Professional from JAPAN on May 11, 2007. Female patient, 60 years of age, was diagnosed with colon cancer recurrent and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: erythema, loss of consciousness. Irinotecan dosage: unknown. Patient recovered.
Irinotecan Side Effects Report #5403207-X
Irinotecan side effect was reported by a Health Professional from JAPAN on July 20, 2007. Female patient, 60 years of age, was diagnosed with colon cancer recurrent and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: erythema, loss of consciousness. Irinotecan dosage: unknown. Patient recovered.
Irinotecan Side Effects Report #5152578-0
Irinotecan side effect was reported by a Consumer or non-health professional from ITALY on May 15, 2002. Female patient, 65 years of age, was diagnosed with colon cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: cachexia, coma, cyanosis, diarrhoea, loss of consciousness, mucosal inflammation, neutropenia, pulmonary embolism
, pulse absent. Irinotecan dosage: 280 MG (ONCE), INTRAVENOUS; SEE IMAGE. During the same period patient was treated with FLUOROURACIL, FOLINIC ACID, FOLINIC ACID, BACITRACINE, FLUCONAZOLE. Patient died on 05/14/2002.Irinotecan Side Effects Report #5042581-3
Irinotecan side effect was reported by a Health Professional from JAPAN on June 06, 2006. Female patient, 43 years of age, was diagnosed with chloroma and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: cardiovascular disorder, cerebral haemorrhage, cyst, diarrhoea, haemoglobin decreased, hepatic steatosis, hyperalbuminaemia, loss of consciousness, metastases to adrenals. Irinotecan dosage: unknown. During the same period patient was treated with CISPLATIN, DESMOPRESSIN ACETATE, THEOPHYLLINE, HUSTAGIN, CODEINE PHOSPHATE, MAGNESIUM OXIDE, PRIMPERAN. Patient recovered.
Irinotecan Side Effects Report #4718968-2
Irinotecan side effect was reported by a Physician from GERMANY on July 12, 2005. Male patient, 63 years of age, weighting 132.3 lb, was treated with Irinotecan. After drug was administered, patient experienced the following side effects: convulsion, disease progression, loss of consciousness. Irinotecan dosage: 136 MG (136 MG, CYCLIC, 3 WEEKLY), INTRAVENEOUS. During the same period patient was treated with CISPLATIN, VIOXX, TRAMADOL, BISOPROLOL FUMARATE, MORPHINE SULPHATE, ALLOPURINOL, THIOCTACID. Patient was hospitalized. Patient died on 08/26/2004.
Irinotecan Side Effects Report #4738644-X
Irinotecan side effect was reported by a Physician from GERMANY on July 27, 2005. Male patient, 63 years of age, weighting 132.3 lb, was treated with Irinotecan. After drug was administered, patient experienced the following side effects: convulsion, loss of consciousness, malignant neoplasm progression, metastases to central nervous system. Irinotecan dosage: 136 MG (136 MG, CYCLIC, 3 WEEKLY), INTRAVENOUS. During the same period patient was treated with CISPLATIN, VIOXX, TRAMADOL, BISOPROLOL FUMARATE, MORPHINE SULPHATE, ALLOPURINOL, THIOCTACID. Patient was hospitalized. Patient died on 08/26/2004.
Irinotecan Side Effects Report #5227900-7
Irinotecan side effect was reported by a Consumer or non-health professional from JAPAN on Jan 23, 2007. Female patient, 56 years of age, was treated with Irinotecan. After drug was administered, patient experienced the following side effects: diarrhoea, inappropriate antidiuretic hormone secretion, loss of consciousness, vomiting. Irinotecan dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5133094-9
Irinotecan side effect was reported by a Physician from JAPAN on Oct 04, 2006. Female patient, 56 years of age, was treated with Irinotecan. After drug was administered, patient experienced the following side effects: diarrhoea, inappropriate antidiuretic hormone secretion, loss of consciousness, vomiting. Irinotecan dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5330517-7
Irinotecan side effect was reported by a Health Professional from JAPAN on May 11, 2007. Male patient, 51 years of age, was treated with Irinotecan. After drug was administered, patient experienced the following side effects: loss of consciousness. Irinotecan dosage: unknown. During the same period patient was treated with CALCIUM FOLINATE, FLUOROURACIL, NASEA, DEXAMETHASONE PHOSPHATE. Patient recovered.
Irinotecan Side Effects Report #5806387-7
Irinotecan side effect was reported by a Consumer or non-health professional from GERMANY on July 01, 2008. Male patient, weighting 132.3 lb, was treated with Irinotecan. After drug was administered, patient experienced the following side effects: convulsion, loss of consciousness. Irinotecan dosage: unknown. During the same period patient was treated with CISPLATIN, VIOXX, TRAMAL, BISOPROLOL FUMARATE, MORPHINE SULPHATE, ALLOPURINOL, THIOCTACID. Patient was hospitalized. Patient died on 08/26/2004.